Anadrol

Anadrol functions by binding to androgen receptors within muscle tissue, stimulating protein synthesis and nitrogen retention. As a 17-alpha-alkylated compound, it is modified to survive the first-pass metabolism in the liver, allowing it to remain active when taken orally. This structural modification is the primary reason for its significant liver strain. The compound also increases red blood cell production, which may enhance oxygen delivery to tissues during intense physical exertion. Unlike some other steroids, Anadrol does not convert to estrogen via aromatase, meaning it does not cause water retention or gynecomastia. However, its strong androgenic nature can lead to rapid changes in body composition. Researchers note that the half-life is relatively short, requiring consistent daily dosing to maintain stable blood levels. The anabolic effect is often described as 'dense' rather than purely volumetric, contributing to a harder muscle appearance.

In athletic research contexts, Anadrol is primarily utilized for mass building and strength enhancement. It is rarely used for cutting cycles due to its tendency to increase water retention and potential for adverse lipid profiles. Athletes typically run this compound during the off-season or early bulking phases when caloric surplus is high. It is often stacked with other anabolic agents to maximize hypertrophy, though this increases the overall toxic load. Some users report using it for short-term strength plateaus, leveraging its rapid onset of action. Because of its potency, it is generally reserved for intermediate to advanced users who have established a solid training base. The compound is not recommended for beginners due to the steep learning curve regarding side effect management. Research protocols often focus on its ability to drive rapid gains in lean tissue mass within a short timeframe, making it a popular choice for pre-competition bulk strategies.

Standard research protocols for Anadrol typically range from 25 mg to 50 mg per day. Beginners or those with lower tolerance may start at the lower end, while advanced users may utilize the higher dose. Cycle length is usually limited to 6 to 8 weeks due to the compound's hepatotoxic nature. Extending the cycle beyond this window significantly increases the risk of liver enzyme elevation and potential damage. It is common to split the daily dose into two administrations to maintain stable plasma levels. For example, a 50 mg daily protocol might be split into 25 mg in the morning and 25 mg in the evening. Stacking Anadrol with other oral steroids is generally discouraged to mitigate liver stress. Instead, it is often paired with injectable compounds that do not carry the same 17-alpha-alkylation burden. Users should monitor their liver function regularly throughout the cycle to ensure safety.

The primary safety concern with Anadrol is hepatotoxicity, as the liver must process the 17-alpha-alkylated structure. Users should undergo regular blood work to monitor liver enzymes (ALT, AST) and bilirubin levels. Other common side effects include acne, hair loss in genetically predisposed individuals, and increased aggression or mood swings. Cardiovascular risks are also significant, with potential decreases in HDL cholesterol and increases in LDL cholesterol. Blood pressure may rise due to increased red blood cell mass and fluid retention. Post-cycle therapy (PCT) is essential to restore natural testosterone production, which is suppressed during use. A standard PCT protocol often includes SERMs like Tamoxifen or Clomiphene. Additionally, users should be aware of the potential for virilization in female subjects, which can be irreversible. Consulting with a healthcare professional before beginning any research protocol is strongly advised.

Mechanism of action

Oxymetholone binds to androgen receptors to stimulate protein synthesis and nitrogen retention, while its 17-alpha-alkylation allows oral bioavailability but increases hepatic metabolic load.